Agent and method for treating cancer comprising strontium, amino acid(s) and mineral agent(s)
AssigneeHelsingfors Institution FöR Biommunterapi AB.
InventorThomas TALLBERG
Life of this patent
Estimating the term…
Abstract
The invention relates to the treatment and prophylaxis of cancer. In particular, the invention relates to a pharmaceutical agent comprising strontium, amino acid(s) and mineral element(s), and its use in the preparation of an agent useful for the treatment and prophylaxis of cancer. The invention also relates to a method for treatment and prophylaxis of cancer.
Claims11
-11. (canceled)
A method for the treatment or prophylaxis of cancer which comprises administering to a subject in need thereof a pharmaceutical agent which consists essentially of strontium, one or more amino acids selected from the group consisting of arginine, serine, asparagine, glycine, glutamine, lysine, one or more mineral elements selected from the group consisting of chromium, tin, vanadium and wolfram and one or more vitamins.
Dependencies are inferred from the claim text.